Imvotamab Antibody
Imvotamab (IGM-2323) is a CD20xCD3 bispecific IgM antibody designed to physiologically activate T cells for targeted elimination of B-cell malignancies. It is being investigated in preclinical and clinical studies for applications in non-Hodgkin's lymphoma and multiple myeloma research.
Product Specifications
Target
Immunology/Inflammation related
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681139-500 1x 500 µL
CD66, pan (CEA) (Cocktail), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
K4026402 1.0 µg DNA
Lpcat1 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 